AnX Robotica Reported AI Performance Results

The company announced that its ProScan AI technology significantly reduced review times for small-bowel capsule endoscopy.

Updated on Oct. 11, 2026 in Artificial Intelligence

Isometric editorial illustration of a medical capsule on a geometric surface, representing advancements in diagnostic AI technology.
AnX Robotica reported that its NaviCam ProScan AI tool significantly reduced review times for small-bowel capsule endoscopy procedures. AI Illustration. Upload story photo >

Live Poll

Do you trust artificial intelligence to assist doctors in diagnosing medical conditions accurately?

AnX Robotica shared new performance results for its NaviCam ProScan AI-assisted reading tool. The technology demonstrated a substantial reduction in the time required for physicians to review small-bowel capsule endoscopy data.

Why it matters

Automated workflows are transforming diagnostic processes by lowering the time burden on clinicians. This development highlights the growing role of specialized artificial intelligence in improving the efficiency of routine medical screenings.

The NaviCam ProScan AI-assisted reading tool reduced mean small-bowel capsule review time by 88.6% when measured against manual reading processes. A recently cleared comparator workflow achieved only a 24.7% reduction in review time.

The players

AnX Robotica

AnX Robotica is a medical technology company based in Plano, Texas, that specializes in AI-assisted capsule endoscopy systems.

The details

The performance metrics for the Plano, Texas-based company were derived from data submitted for FDA evaluation. This technology aims to replace slower manual review processes for endoscopy data with automated, AI-assisted workflows.

Timeline

  1. AnX Robotica highlighted the ProScan clinical performance results on October 11, 2026.

The Tech Race

The development of the NaviCam ProScan AI-assisted capsule endoscopy reading technology represents a shift toward higher automation in clinical diagnostics. It positions the firm against other developers currently vying for regulatory clearance in the competitive medical imaging market.

Patients may experience faster diagnostic turnaround times as clinicians adopt these more efficient AI-assisted review tools. These advancements are designed to streamline medical workflows, potentially reducing wait times for endoscopy results.

The takeaway

Clinicians are increasingly leveraging AI to process large volumes of visual medical data more quickly. As these tools become more prevalent, the primary goal for healthcare providers will be balancing these speed improvements with consistent diagnostic accuracy.

Further reading

For additional context on how machines are changing diagnostics, explore the Artificial Intelligence section.

Live Poll

Do you trust artificial intelligence to assist doctors in diagnosing medical conditions accurately?